The nephrology landscape has changed significantly over the last 45 years. We are providing more options for patients and utilizing safer and more advanced technology, and remain grounded in a desire to continue to improve. In a description of the nurse's role during hemodialysis in 1950, responsibilities included technical aspects of the treatment, infection prevention, patient assessment and monitoring, documentation, medication administration, fluid management, patient education, and providing comfort and encouragement (Coleman & Merrill, 1952). Although the manner in which these roles are carried out has changed with time, the skills remain important today. Additionally, despite the technological differences throughout the last several decades, nephrology nursing has remained focused on humanizing the process for people with complex care needs, preserving the patient's dignity, teaching, supporting, and involving the patient and family in their care (Hoffart, 1986b). Throughout our historical journey, it is apparent that nephrology nurses have always been responsible for a significant amount (or majority) of the care of patients with kidney disease and that nursing care is much more than delivering a treatment (Lynaugh & Fairman, 1989). Nephrology nursing is grounded in patient and family-centered care based on both physiological and psychosocial needs. Nephrology nurses have touched every aspect of the kidney care community shaping the service, government, and product sectors. Nephrology nursing has been vital from the initial development years and continues to be an undeniable force in improving nephrology care to a patient population with very complex patient needs. Many changes have taken place since the inception of the ESRD program in July 1973. Advances in technology, demonstration projects, research, and reimbursement changes have reshaped the landscape of our care delivery models. In the same way, our knowledge of kidney disease has progressed substantially, resulting in improved diagnosis and treatment in an effort to reduce complications and improve outcomes for patients with ESRD.

Download full-text PDF

Source

Publication Analysis

Top Keywords

nephrology nursing
16
care
9
nephrology
8
nursing care
8
nephrology nurses
8
kidney disease
8
patient
6
nursing
5
changing landscape
4
landscape nephrology
4

Similar Publications

Introduction: To identify key technologies within non-bioartificial liver (NBAL, an extracorporeal support system that temporarily replaces some of the liver's functions) nursing to offer guidance for clinical practice. In the context of NBAL nursing, key technologies are crucial for successful implementation of artificial liver treatment, ensuring patient safety, and enhancing nursing quality. A review of both domestic and foreign literature revealed that studies on NBAL nursing technology are lacking and that the key technologies for NBAL nursing have not been clearly identified.

View Article and Find Full Text PDF

Background: Diabetes is the leading cause of kidney disease and contributes to 38% of kidney failure requiring dialysis. A gap in detection and management of type 2 diabetes (T2D) in chronic kidney disease (CKD) exists in primary care. Community pharmacists are positioned to support those not able to access kidney care through traditional pathways.

View Article and Find Full Text PDF

Objectives: Chronic kidney disease (CKD) is a global health challenge that affects patients' symptom burden and quality of life. Palliative care interventions show promise in addressing the multiple needs of CKD patients, focusing on symptom management, psychosocial support, and advance care planning. This study aimed to evaluate the effectiveness of palliative care interventions in improving symptom management in patients with CKD.

View Article and Find Full Text PDF

Hypercalcemia of malignancy (HCM) is the most common cause of hypercalcemia in hospitalized patients. The pathogenesis of HCM is often multifactorial. One of the rare causes of HCM is extra-renal production of 1,25-dihydroxyvitamin D (or calcitriol), which is often seen in patients with lymphoproliferative malignancies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!